Cita APA (7a ed.)

Li, H., Ma, Z., Li, B., Pan, Y., Xiang, J., Zhang, Y., . . . Hu, H. (2021). Potential utility of longitudinal somatic mutation and methylation profiling for predicting molecular residual disease in postoperative non‐small cell lung cancer patients. Wiley.

Cita Chicago Style (17a ed.)

Li, Hang, et al. Potential Utility of Longitudinal Somatic Mutation and Methylation Profiling for Predicting Molecular Residual Disease in Postoperative Non‐small Cell Lung Cancer Patients. Wiley, 2021.

Cita MLA (8a ed.)

Li, Hang, et al. Potential Utility of Longitudinal Somatic Mutation and Methylation Profiling for Predicting Molecular Residual Disease in Postoperative Non‐small Cell Lung Cancer Patients. Wiley, 2021.